Consequently, we performed meta-analysis revealing that this injection is efficacious in VMC treatment, leading to notable decreases in myocarditis-associated clinical indicators such as CK-MB, cTnT, and H-FABP [57,58]. This evidence concerns the gene TNNT2 and myocarditis.